Obesity-Related Disorders in Türkiye: A Multi Center, Retrospective, Cross-Sectional Analysis from the OBREDI-TR Study
Alihan Oral, İhsan Solmaz, Nizameddin Koca, Ulaş Serkan Topaloğlu, İsmail Demir, Ahmet Sedat Dündar, Ali Kırık, Özge KAMA BAŞCI, Hacer Şen, Emine Binnetoglu, Nalan Okuroğlu, Ahmet Aydın, Zeynep Irmak Kaya, Hamit Yıldız, Aycan Acet, Gökhan Tazegül, Hasan Sözel, Osman Özüdoğru, Kubilay İşsever, Selçuk Yaylacı, Uğur Korkmaz, Nur Düzen Oflas, Celalettin Küçük, Kamil Konur, Teslime Ayaz, Aysun Işıklar, Eşref Araç, Hilmi Erdem Sumbul, Huseyin Ali Ozturk, Ali Burak Govez, Yusuf Usame Durmus, Attila Önmez, Sıbel Ocak Serın, Nazif Yalçın, Ayşegül Ertınmaz, Alper Tuna Güven, Mehmet Kök, Yasin Şahintürk, Seyit Uyar
Abstract
Objectives: Obesity is a significant public health concern, as it is associated with the development of numerous chronic diseases. The prevalence of obesity and attendant diseases has been increasing over recent years. This study attempted to ascertain the frequency of chronic diseases in obese patients in Türkiye for the first time on this scale. Methods: A retrospective study was conducted, with patients admitted to the internal medicine outpatient clinics or obesity centers between December 2023 and December 2024 included in this study. Participants were recruited from seven regions, 20 provinces, and 28 centers, and the inclusion criteria were met by those aged 18 years and over with a body mass index (BMI) of 30 kg per square meter (kg/m2) or above. Their status, with respect to chronic diseases, and their anthropometric parameters were documented. Results: The total number of patients was 10,121, with a mean age of 45.2 ± 13.92. Of these, 7222 (71.35%) were female. The prevalence of type 2 diabetes mellitus (T2DM), hypertension (HT), dyslipidemia (DL), coronary artery disease (CAD), obstructive pulmonary disease (OPD), obstructive sleep apnea syndrome (OSAS), and fatty liver disease (FLD) was found to be 35.01%, 78.19%, 12.37%, 10.32%, 5.88%, and 75.12%, respectively. A subsequent analysis of the prevalence of these diseases by region revealed a statistically significant variation between regions (p < 0.001 for all regions). Conclusions: This study represents a substantial contribution to the existing body of knowledge in this field, particularly with regard to the identification of the current chronic disease rate of obese patients in Türkiye.